TDA's sbir phase II H2-0747 enhanced combat tourniquet with modular wound infection prevention capabilities
Ended Definitive Contract Awarded Last action
- Contract number
- HT942523C0025
- Awardee
-
TDA Research, Inc. UEI MK5ANJVWVZK7
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $1,099,998
Award facts
- Opportunity
-
- HQ003420RBDST Solicitation number
- Contract value 100% obligated
- $1,099,998.07 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 3 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Denver, CO 80033, USA
- Research
- SBIR Program Phase II Action
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $1,099,998 |
About this award
The Defense Health Agency awarded a $1.1 million Small Business Innovation Research (SBIR) Phase II contract to TDA Research, Inc., a small business specializing in advanced research and medical device development headquartered in Golden, Colorado. The contract, designated as a total small business set-aside, runs through August 31, 2026, and funds development of an enhanced combat tourniquet with modular wound infection prevention capabilities. This effort builds on earlier Phase I research to advance a medical device with potential applications for combat casualty care, leveraging TDA Research's extensive experience delivering innovative solutions across defense, medical device, and advanced materials domains through SBIR and STTR programs with federal agencies.
TDA Research engaged Arkansas Children's Research Institute (ACRI), a non-profit pediatric medical research institution, as a subcontractor beginning in February 2025. ACRI is conducting specialized pharmacokinetic research to determine whether ertapenem, an antibiotic, maintains elevated local concentration within an ischemic limb during tourniquet application compared to systemic circulation and the contralateral limb. This research directly supports the infection prevention objectives of the enhanced tourniquet system by evaluating antibiotic efficacy under tourniquet conditions, combining TDA Research's device engineering expertise with ACRI's specialized medical research and laboratory capabilities to develop a comprehensive combat medical solution.
Subawards
| Subcontractor | Amount | Awarded |
|---|---|---|
| Arkansas Children's Research Institute | $101,562 | |
| The Research Foundation For The State University Of New York | $251,952 |
Quick answers
Who was awarded contract HT942523C0025?
HT942523C0025 was awarded to TDA Research, Inc. by Defense Health Agency (Department of Defense) on May 1, 2023.
How much is contract HT942523C0025 worth?
The government has obligated $1,099,998 on HT942523C0025.
Was contract HT942523C0025 competed?
The extent of competition for HT942523C0025 was full and open competition after exclusion of sources. The government received 3 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award